JUN 16, 202649 MINS READ
Borosilicate glass is defined by its multi-component oxide composition, wherein silicon dioxide (SiO₂) forms the primary network former, and boron trioxide (B₂O₃) acts as both a network former and flux, reducing melting temperature and modifying thermal expansion behavior 1,2. Typical formulations contain 60–85 wt% SiO₂, 5–20 wt% B₂O₃, and 0–17 wt% Al₂O₃, with alkali oxides (Li₂O, Na₂O, K₂O) and alkaline earth oxides (MgO, CaO, SrO, BaO) introduced to tailor viscosity, chemical resistance, and mechanical properties 2,5,6.
The structural role of boron is complex: at low alkali content, boron predominantly exists in trigonal BO₃ units, which create non-bridging oxygen sites and lower glass transition temperature (Tg); with increasing alkali oxide concentration, boron converts to tetrahedral BO₄⁻ units charge-balanced by alkali cations, enhancing network connectivity and chemical durability 2,15. Aluminum oxide (Al₂O₃) further stabilizes the network by forming AlO₄⁻ tetrahedra, improving hydrolytic resistance and mechanical strength, particularly in pharmaceutical-grade compositions 5,6,18.
Recent formulations emphasize precise control of the molar ratio [Al₂O₃]/([SiO₂]+[B₂O₃]) ≤ 0.015 to optimize basicity (≥0.485) and achieve superior heat-shielding properties in automotive glazing applications 14,20. Iron oxide (Fe₂O₃) at 0.10–1.0 wt% is intentionally added to modulate near-infrared (NIR) absorption, with transmittance at 900–1300 nm reduced by 5–15% upon thermal bending, enhancing solar control without compromising visible light transmission (≥78% at 500 nm for 2 mm thickness) 8,12,14.
Key compositional parameters include:
Advanced compositions for electronic substrates achieve elastic modulus >82 GPa, strain point ≥690°C, and density <2.55 g/cm³ by optimizing SiO₂ (59–69 mol%), B₂O₃ (5–11.5 mol%), Al₂O₃ (8–15.5 mol%), and incorporating Y₂O₃ (0.1–0.6 mol%) and ZrO₂ (0.5–1.5 mol%) to enhance rigidity and thermal stability 19.
Borosilicate glass exhibits a coefficient of thermal expansion (CTE) in the range of 30–55×10⁻⁷/°C (20–300°C), significantly lower than soda-lime glass (90×10⁻⁷/°C), conferring exceptional thermal shock resistance 2,15,19. This property is critical for applications involving rapid temperature cycling, such as laboratory glassware (withstanding ΔT ≥150°C) and cookware 1,18.
Mechanical strength is quantified by elastic modulus (E), which ranges from 60 to 82 GPa depending on composition. Alkali-free formulations optimized for display substrates achieve E >82 GPa, strain point Ts ≥690°C, and Vickers hardness 550–600 HV, meeting the rigidity requirements for large-format (Gen 8+) TFT-LCD and OLED panels 19. Ion-exchange strengthening (immersion in molten KNO₃ at 400–500°C for 4–16 hours) induces compressive stress layers (CS 600–900 MPa, depth of layer DOL 30–80 μm), increasing flexural strength from ~70 MPa (annealed) to >200 MPa (strengthened) 16,18.
Thermal stability is characterized by glass transition temperature (Tg 500–560°C), softening point (Ts 700–820°C), and annealing point (Ta 550–600°C). High-temperature viscosity at 1300°C (log η ≈ 3–4 dPa·s) facilitates tube drawing and pressing operations, while viscosity at Tg (log η ≈ 12 dPa·s) defines the upper service temperature for dimensional stability 1,9,18.
Key thermal and mechanical data:
Thermal shock resistance is quantified by the parameter R = σ·(1−ν)/(E·α), where σ is tensile strength, ν is Poisson's ratio, E is elastic modulus, and α is CTE. Borosilicate glass achieves R values 3–5× higher than soda-lime glass, enabling survival of quenching from 200°C into ice water without fracture 1,18.
Borosilicate glass is renowned for its superior chemical resistance, classified as Hydrolytic Class 1 (ISO 719), Acid Class 1 (ISO 1776), and Alkali Class 2 (ISO 695) 5,6,18. Hydrolytic stability is measured by the release of Na₂O equivalents (μg/g glass) after autoclaving powdered glass (300–500 μm) in water at 121°C for 60 minutes; Class 1 requires ≤62 μg/g 5,18.
Pharmaceutical-grade formulations (e.g., Type I borosilicate per USP <660>) contain 70.5–76.5 wt% SiO₂, 6.5–11.5 wt% B₂O₃, 4–8 wt% Al₂O₃, and 5.5–10.5 wt% total alkali oxides, achieving hydrolytic resistance suitable for parenteral drug packaging (vials, ampoules, syringes) 5,6,18. The absence of BaO, As₂O₃, and Sb₂O₃ ensures compliance with pharmaceutical and environmental regulations (REACH, FDA 21 CFR 177.1010) 5,18.
Acid resistance (Class 1) is verified by weight loss <0.7 mg/dm² after 6-hour immersion in 6 M HCl at 100°C (ISO 1776). Alkali resistance (Class 2) permits weight loss <75 mg/dm² after 3-hour exposure to 1 M NaOH + 0.5 M Na₂CO₃ at 100°C (ISO 695); incorporation of 0.5 wt% ZrO₂ upgrades alkali resistance to Class 1 (<35 mg/dm²) 18.
Chemical durability mechanisms include:
For biopharmaceutical applications, delamination resistance is critical. Formulations with <0.02 wt% chemical oxygen demand (COD) in silicate precursors and controlled sulfate/nitrate refining suppress formation of alkali-rich surface layers that cause flaking upon autoclaving 3,9.
Borosilicate glass production involves batch preparation, melting, refining, homogenization, forming, and annealing. Raw materials include high-purity quartz sand (SiO₂), boric acid (H₃BO₃) or borax (Na₂B₄O₇·10H₂O), aluminum hydroxide (Al(OH)₃), and alkali/alkaline earth carbonates or nitrates 1,3,9,10.
Batch components are weighed to achieve target oxide composition, with typical batch-to-glass conversion efficiency 85–90%. Refining agents include sulfates (0.1–0.8 wt% SO₃) 1, nitrates (0.5–2 wt%) 3,9, or halides (Cl⁻ 1.5–2.5 wt%) 16 to eliminate dissolved gases (CO₂, H₂O, O₂) and reduce bubble content to <0.1 bubbles/kg.
Melting occurs in platinum-lined or refractory-lined furnaces at 1400–1650°C for 12–24 hours. High-purity formulations for pharmaceutical tubing require silicate precursors with COD <200 ppm (<0.02 wt%) to prevent organic contamination and delamination 3,9. Controlled atmosphere melting (reducing or oxidizing) adjusts redox state (Fe²⁺/Fe³⁺ ratio) to optimize UV absorption and color 8,12,13.
Refining at 1450–1550°C for 4–8 hours promotes bubble rise and coalescence. Sulfate refining releases SO₂ gas, while nitrate refining generates O₂; halide refining (Cl⁻, Br⁻) lowers surface tension, facilitating bubble removal 1,3. Homogenization via stirring or bubbling ensures compositional uniformity (±0.5 wt% oxide variation) and eliminates striae 1,9.
Annealing at Ta ±20°C (550–600°C) for 1–4 hours relieves residual stress (<10 MPa birefringence). Ion-exchange strengthening in molten KNO₃ (400–500°C, 4–16 hours) replaces surface Na⁺ with K⁺, inducing compressive stress (CS 600–900 MPa, DOL 30–80 μm) and increasing impact resistance 3–5× 16,18.
Thermal tempering (heating to 650–700°C, rapid air quenching) generates surface compression (CS 80–120 MPa) but is less effective than ion-exchange due to low CTE 18.
Type I borosilicate glass (USP <660>, Ph. Eur. 3.2.1) is the gold standard for parenteral drug containers, offering Hydrolytic Class 1 stability, minimal ion leaching (<1 ppm Na⁺, <0.1 ppm Al³⁺ after 121°C autoclaving), and compatibility with biologics (monoclonal antibodies, vaccines, gene therapies) 5,6,18. Formulations contain 70.5–76.5 wt% SiO₂, 6.5–11.5 wt% B₂O₃, 4–8 wt% Al₂O₃, and are free of BaO, As₂O₃, Sb₂O₃ to meet FDA and EMA requirements 5,18.
Delamination resistance is achieved by using silicate precursors with COD <200 ppm and optimizing alkali oxide ratios (Li₂O 0.5–2 wt%, Na₂O 4.5–9 wt%) to prevent phase separation during autoclaving 3,9. Surface treatment with ammonium sulfate or silane coupling agents enhances protein adsorption resistance and reduces particulate shedding 17.
Case Study: Enhanced Delamination Resistance In Prefilled Syringes — Pharmaceutical
A leading pharmaceutical glass manufacturer implemented low-COD silicate precursors (<0.02 wt%) and sulfate refining (0.3 wt% SO₃) to produce 1 mL prefilled syringes with delamination rate <0.01% after 100 autoclave cycles (121°C, 20 min), meeting ISO 11040-4 requirements for combination products 3,9.
Borosilicate glass with controlled Fe₂O₃ content (0.10–1.0 wt%) and optimized basicity (≥0.485) achieves selective NIR absorption, reducing solar heat gain by 15–25% compared to standard soda-lime glass 8,12,14. Transmittance at 900–1300 nm decreases from Tb (as-formed) to Ta (after thermal bending at T₁₂ ≥10¹² dPa·s), with ΔT = Tb − Ta >0, enhancing cabin comfort and reducing HVAC energy consumption by 10–15% 8,12.
Laminated structures (borosilicate outer ply 2 mm / PVB interlayer 0.76 mm / soda-lime inner ply 2 mm) provide impact resistance (ECE R43), UV blocking (>99% at <380 nm), and acoustic damping (STC 35–
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| SCHOTT AG | Pharmaceutical primary packaging including vials, ampoules, and prefilled syringes for biologics, vaccines, and high-efficacy drug solutions requiring superior chemical resistance and delamination prevention. | FIOLAX Type I Pharmaceutical Tubing | Hydrolytic Class 1 stability with sulfate refining (0.01-0.8 wt% SO₃), achieving <62 μg/g Na₂O equivalent leaching after autoclaving, meeting USP <660> and ISO 719 standards for parenteral drug packaging. |
| NIPPON ELECTRIC GLASS CO. LTD. | High-purity pharmaceutical containers for chemically unstable and highly reactive drug solutions, including prefilled syringes and vials for combination products in biopharmaceutical applications. | Pharmaceutical Borosilicate Glass Tubing | Delamination-resistant formulation using silicate precursors with COD <200 ppm (<0.02 wt%) and nitrate refining, achieving <0.01% delamination rate after 100 autoclave cycles at 121°C, compliant with ISO 11040-4. |
| AGC Inc. | Automotive windshields and side windows requiring solar control and thermal comfort, reducing HVAC energy consumption by 10-15% in passenger vehicles while meeting ECE R43 safety standards. | Automotive Heat-Shielding Glazing | Controlled Fe₂O₃ content (0.10-1.0 wt%) and optimized basicity (≥0.485) achieve 15-25% reduction in solar heat gain with NIR transmittance decrease of 5-15% after thermal bending, while maintaining visible light transmission ≥78% at 500 nm for 2 mm thickness. |
| Corning Incorporated | Lab-on-a-chip platforms, microfluidic channels, and biosensor substrates requiring precise sintering, chemical durability, and compatibility with biological reagents in diagnostic and analytical applications. | Microfluidic Device Substrates | Devitrification-resistant composition (60-74 wt% SiO₂, 9-25 wt% B₂O₃, 7-17 wt% Al₂O₃) with CTE 30-55×10⁻⁷/°C enables sintering at 700-800°C without crystal formation or inhibitor oxide addition, maintaining mechanical strength and dimensional stability. |
| CNBM RESEARCH INSTITUTE FOR ADVANCED GLASS MATERIALS GROUP CO. LTD. | Large-format (Gen 8+) display substrates for TFT-LCD and OLED panels requiring high dimensional stability, thermal resistance, and mechanical strength for precision electronic device manufacturing. | High-Generation TFT-LCD/OLED Substrates | Alkali-free composition achieving elastic modulus >82 GPa, strain point ≥690°C, density <2.55 g/cm³, and CTE 35-39×10⁻⁷/°C through optimized SiO₂ (59-69 mol%), B₂O₃ (5-11.5 mol%), Al₂O₃ (8-15.5 mol%), with Y₂O₃ and ZrO₂ additions for enhanced rigidity. |